These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26079155)

  • 1. Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis.
    Hua-Huy T; Le-Dong NN; Duong-Quy S; Bei Y; Rivière S; Tiev KP; Nicco C; Chéreau C; Batteux F; Dinh-Xuan AT
    J Breath Res; 2015 Jun; 9(3):036007. PubMed ID: 26079155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
    Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
    Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
    Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
    Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
    Morozan A; Joy S; Fujii U; Fraser R; Watters K; Martin JG; Colmegna I
    Sci Rep; 2023 Nov; 13(1):20577. PubMed ID: 37996447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
    Bagnato G; Bitto A; Irrera N; Pizzino G; Sangari D; Cinquegrani M; Roberts W; Atteritano M; Altavilla D; Squadrito F; Bagnato G; Saitta A
    Arthritis Res Ther; 2013 Sep; 15(5):R120. PubMed ID: 24286160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis.
    Bagnato GL; Irrera N; Pizzino G; Santoro D; Roberts WN; Bagnato G; Pallio G; Vaccaro M; Squadrito F; Saitta A; Altavilla D; Bitto A
    Clin Sci (Lond); 2018 Jan; 132(2):231-242. PubMed ID: 29237724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
    Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
    Front Immunol; 2019; 10():1861. PubMed ID: 31481954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosis.
    Raker VK; Ook KY; Haub J; Lorenz N; Schmidt T; Stegemann A; Böhm M; Schuppan D; Steinbrink K
    Exp Dermatol; 2016 Nov; 25(11):887-894. PubMed ID: 27307019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
    Maria ATJ; Toupet K; Maumus M; Rozier P; Vozenin MC; Le Quellec A; Jorgensen C; Noël D; Guilpain P
    Front Immunol; 2018; 9():2571. PubMed ID: 30455706
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis.
    Fineschi S; Bongiovanni M; Donati Y; Djaafar S; Naso F; Goffin L; Argiroffo CB; Pache JC; Dayer JM; Ferrari-Lacraz S; Chizzolini C
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):458-65. PubMed ID: 18458239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis.
    Maria ATJ; Rozier P; Fonteneau G; Sutra T; Maumus M; Toupet K; Cristol JP; Jorgensen C; Guilpain P; Noël D
    Front Immunol; 2018; 9():3056. PubMed ID: 30622540
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury.
    Leach HG; Chrobak I; Han R; Trojanowska M
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1093-101. PubMed ID: 23885794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.
    Liang M; Lv J; Zou L; Yang W; Xiong Y; Chen X; Guan M; He R; Zou H
    Lab Invest; 2015 Mar; 95(3):342-50. PubMed ID: 25502178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide prevents ROS-induced systemic fibrosis in mice.
    Morin F; Kavian N; Chouzenoux S; Cerles O; Nicco C; Chéreau C; Batteux F
    Free Radic Biol Med; 2017 Jul; 108():192-203. PubMed ID: 28365359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis.
    Hua-Huy T; Tiev KP; Chéreau C; Duong-Quy S; Cabane J; Dinh-Xuan AT
    J Rheumatol; 2010 Aug; 37(8):1680-7. PubMed ID: 20595271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
    Orvain C; Cauvet A; Prudent A; Guignabert C; Thuillet R; Ottaviani M; Tu L; Duhalde F; Nicco C; Batteux F; Avouac J; Wang N; Seaberg MA; Dillon SR; Allanore Y
    Arthritis Res Ther; 2022 Jan; 24(1):13. PubMed ID: 34986869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelatinases Increase in Bleomycin-induced Systemic Sclerosis Mouse Model.
    Vafashoar F; Mousavizadeh K; Poormoghim H; Tavasoli A; Musavi Shabestari T; Javadmoosavi SA; Mojtabavi N
    Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):182-189. PubMed ID: 31066254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.